D-Ribose Improves Diastolic Function and Quality of Life in Congestive Heart Failure Patients: A Prospective Feasibility Study
Omran H, Illien S, MacCarter D, St Cyr J, Luderitz B
Published in European Journal of Heart Failure
Methodology
Randomized double-blind placebo-controlled crossover feasibility study of D-ribose 15 g/day for 3 weeks in 15 patients with chronic coronary artery disease and congestive heart failure.
Key Findings
D-ribose improved echocardiographic diastolic filling parameters and quality-of-life scores compared with placebo; exercise capacity was not significantly changed.
Conclusions
D-ribose showed preliminary benefit for diastolic function in heart failure, requiring confirmation in larger trials.
Limitations
Very small sample; short crossover; industry-linked authorship; surrogate endpoints.
Supplements Studied
D-ribose improved echocardiographic diastolic filling parameters and quality-of-life scores compared with placebo.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.